|
|
|
|
Vol. 59, Issue 6, 1410-1417, June 2001
4
4 Nicotinic Receptor Subtype Is Present in Chick
Retina: Identification, Characterization and Pharmacological Comparison
with the Transfected
4
4 and
6
4 Subtypes
Department of Experimental Medicine and Pathology, La Sapienza University, Rome (B.B.); Department of Biochemistry, Science II, University of Geneva, Geneva, Switzerland (B.B.); CNR Cellular and Molecular Pharmacology Center, Department of Medical Pharmacology, University of Milan, Milan, Italy (S.V., M.M., F.C., C.G.); Department of Biology, University of Utah, Salt Lake City, Utah (J.M.M.); and CNR Center for Hormone Chemistry, Milan, Italy (R.L.)
| |
Abstract |
|---|
|
|
|---|
Retina from 1-day-old chicks is a valuable tissue model for studying
neuronal nicotinic receptors because it expresses a large number of the
developmentally regulated high affinity [3H]epibatidine
labeled nicotinic receptors. Most of these receptors contain the
4
subunit associated with different
subunits. Using a sequential
immunodepletion procedure with anti-
6, anti-
3, anti-
2, and
anti-
4 antibodies, we purified an
4
4 nicotinic receptor
subtype that accounts for approximately 20 to 25% of the high affinity
[3H]epibatidine labeled receptors present in
retina at that developmental time. Immunoprecipitation and Western
blotting experiments confirmed that the purified subtype contains only
the
4 and
4 subunits. This receptor binds a number of agonists
and the antagonist dihydro-
-erythroidine with nanomolar affinity,
whereas it has micromolar affinity for the
-conotoxin MII and
methyllycaconitine toxins and other nicotinic antagonists. Comparison
of the pharmacological profile of this purified native subtype with
that of the same subtype transiently expressed in human BOSC23 cells
showed that they have very similar rank orders and absolute
Ki values for several nicotinic drugs. Finally, because
chick retina expresses an
6
4-containing subtype with a high
affinity for the
-conotoxin MII, we used native and transfected
4
4 and
6
4 subtypes to investigate the relative contributions of the
and
subunits to this binding, and found that the
6 subunit determines the high affinity for this toxin.
| |
Introduction |
|---|
|
|
|---|
Acetylcholine
(ACh) binds to two major subclasses of cholinergic receptors in the
central nervous system (CNS): the muscarinic and neuronal nicotinic ACh
receptors (nAChRs), which mediate not only between-neuron
communications but also the long-lasting modifications that occur
during development. ACh acts on muscarinic ACh receptors to regulate
cell proliferation and on nAChRs to regulate neurite outgrowth and
pathfinding by neuronal growth cones (reviewed in Role and Berg, 1996
;
Zoli, 2000
).
nAChRs are cationic channels whose opening is controlled by ACh. They
are mainly involved in fast synaptic transmission in the autonomic
nervous system (Berg et al., 2000
), but also have regulatory functions
in the CNS. Brain nAChRs are predominantly localized at presynaptic
sites, where they influence the activity of various neurotransmission
systems by regulating the release of specific neurotransmitters, such
as ACh, dopamine, norepinephrine, serotonin,
-aminobutyric acid, and
glutamate (reviewed in Wonnacott, 1997
; MacDermott et al., 1999
).
nAChRs include a variety of subtypes, a heterogeneity that is
attributable mainly to the diversity of the genes encoding the receptor
subunits. Twelve vertebrate genes coding for nAChR subunits have so far
been cloned (
2-
10 and
2-
4), and a number of subtypes with
different pharmacological and functional properties can be generated
from the homopentameric or heteropentameric assembly of these subunits
in heterologous systems. The homomeric channels can be obtained by the
expression of
7,
8, or
9 subunits, whereas the heteromeric
channels come from the coexpression of different combinations of
2,
3,
4, or
6 and
2 or
4 in presence or absence of
5 or
3 subunits (reviewed in McGehee and Role, 1995
; Gotti et al.1997
;
Clementi et al., 2000
; Lindstrom, 2000
).
The pharmacological and functional properties of nAChR subtypes are
mainly determined by the pentameric arrangements of their subunits,
although post-translational events, transport to different membrane
regions, and/or binding to linker proteins can also affect their
function. The fact that more than one type of
or
subunit can
coassemble in a single pentameric receptor greatly increases the number
of possible receptor subtypes present in the nervous system, but not
all of these potential subtypes are actually expressed because some
still unknown mechanisms prevent the formation of some possible subunit
combinations (reviewed in Lindstrom, 2000
).
Given that the effects of ACh on neuronal development and functions after the establishment of synaptic contacts depend on the nAChR subtype expressed at each stage, it is very important to identify and investigate the properties of the subtypes expressed in the nervous systems.
7 and
4
2 are the predominant subtypes expressed in vertebrate
brain, whereas the
3
4 subtype predominates in the autonomic nervous system (Gotti et al., 1997
; Lindstrom, 2000
). However, subtypes
containing the
2,
5,
6,
3, and
4 subunits can be found
in more limited CNS regions (Forsayeth and Kobrin, 1997
; Lindstrom,
2000
). The presence of these minor subtypes is also suggested by
studies on knock-out animals: functional and ligand binding studies of
animals lacking the
2 subunit suggest that
4-containing receptors
are also present in restricted areas associated with an
3,
2, or
4 subunit (Picciotto et al., 1995
; Zoli et al., 1998
).
Because selective ligands for specific nAChR isoforms are still scarce,
our group has devised an alternative approach toward identifying and
characterizing the native subtypes present in the chick nervous system
by preparing a series of antibodies (Abs) that specifically recognize
all of the known subunits. Using this approach, we have recently been
able to identify several new subtypes:
6- and
3-containing
receptors in retina (Vailati et al., 1999
, 2000
), and the
2
5
2
subtype in chick optic lobe (Balestra et al., 2000
).
In this study, we used a sequential immunodepletion procedure to
identify the presence of an
4
4 subtype in chick retina, and then
characterized its subunit composition and pharmacological profile and
compared it with that of the transfected
4
4 subtype.
Furthermore, to study the relative contribution of the
or
subunits to the pharmacological profiles of the subtypes, we compared
the pharmacological properties of the transfected chick
4
4 and
6
4 subtypes.
| |
Experimental Procedures |
|---|
|
|
|---|
Antibody Production and Characterization.
The polyclonal Abs
against the
2,
3,
4,
5,
6
7,
8,
2,
3, and
4 chick peptides were raised and characterized as described by
Vailati et al. (1999
, 2000
) and Balestra et al. (2000)
. For most of the
subunits, two different peptides were chosen: one located in the
cytoplasmic loop between M3 and M4 (CYT), and the other located at the
COOH terminal (COOH). Each anti-peptide Ab was affinity purified by
incubating the serum with an affinity resin made by coupling the
corresponding peptide to CNBr-activated Sepharose 4B (Amersham
Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer's
instructions. The monoclonal Ab 299 raised against rat brain nAChR and
directed against the
4 subunit (Whiting and Lindstrom, 1988
) was
purchased from RBI. The affinity-purified Abs were bound to
CNBr-activated Sepharose at a concentration of 1 mg/ml, and the columns
used for immunopurification.
Receptor Subtype Immunopurification
The
4
4 Subtype.
The retina extracts were prepared as
previously described by Vailati et al. (1999)
; every experiment
involved the use of 150 g of chick eyes. The tissue was
homogenized in an excess of 50 mM sodium phosphate, pH 7.4, 1 M NaCl, 2 mM EDTA, 2 mM EGTA, and 2 mM PMSF for 2 min in an ultraTurrax
homogenizer. The homogenate was then diluted and centrifuged for
1.5 h at 60,000g.
6 Abs to remove the
6 receptors, and then twice with 5 ml of
Sepharose-4B with anti-
3 Abs to remove the residual
3-containing
receptors. The flow-through of the
3 column was reincubated with 5 ml of Sepharose-4B with anti-
2 Abs, and the resulting
2
flow-through incubated with 5 ml of Sepharose-4B with anti-
4 Abs;
the bound receptors were eluted with 0.2 M glycine, pH 2.2, or by
competition with 100 µM the corresponding
4 peptide used for Ab production.
Receptor Immobilization by Subunit-Specific Antibodies.
The affinity-purified anti-
4 or anti-
4 Abs were bound to
microwells (Maxi-Sorp; Nunc, Wiesbaden, Germany) by means of overnight incubation at 4°C at a concentration of 10 µg/ml in 50 mM phosphate buffer, pH 7.5. On the following day, the wells were washed to remove
the excess of unbound Abs, and then incubated overnight at 4°C with
200 µl of 2% Triton X-100 retina membrane extract containing 50 to
100 fmol of [3H]Epi binding sites, which was
prepared by sequentially immunodepleting the extract with the
anti-
6, anti-
3, and anti-
2 Abs as described above. After
incubation, the wells were washed and the presence of immobilized
receptors revealed by means of [3H]Epi binding.
Immunoprecipitation of [3H]Epi-Labeled Receptors by Anti-Subunit Specific Abs during Retina Development.
The subunit content of the purified and transfected
4
4
subtypes was determined by immunoprecipitation using chick
subunit-specific Abs as described previously (Vailati et al., 1999
,
2000
; Balestra et al., 2000
).
The eyes and retinas were dissected from in ovo chicks on embryonic
days 7, 11, 14, and 18 (E7, E11, E14, and E18) and from 1-day-old
chicks (P1), immediately frozen in liquid nitrogen and stored at
80°C for later use. No differences in the binding properties of the
fresh and frozen tissues were observed. For every experiment, the
extracts of the tissues were prepared as described above, labeled with
2 nM [3H]Epi, and incubated overnight with a
saturating concentration of affinity-purified IgG (20 to 30 µg). The
immunoprecipitation was recovered by incubation of the samples with
beads with bound goat anti-rabbit IgG (Tecnogenetics, Milau,
Italy). The level of Ab immunoprecipitation was expressed as the
percentage of [3H]Epi-labeled receptors
immunoprecipitated by the indicated antibodies, taking the amount
present in the Triton X-100 extract solution before immunoprecipitation
as 100%.
Binding Assay and Pharmacological Experiments
(±)-[3H]Epi with a specific activity of
66.6 Ci/mmol was purchased from PerkinElmer Life Science Products
(Boston, MA); nonradioactive Epi was from RBI/Sigma (Natick,
MA). The drugs MG624 and F3 have been synthesized in our laboratory
according to Gotti et al. (1998)
.
-Conotoxin MII (MII) was a
generous gift from M. M.; nonradioactive
-bungarotoxin
(
Bgtx) and the drugs cytisine (Cyt), ACh, carbamylcholine (Carb),
1,1-dimethyl-4-phenylpiperazinium (DMPP), nicotine (Nic), methyllycaconitine (MLA), dihydro-
-erythroidine (DH
E), MII, d-Tubocurarine (d-TC), hexamethonium (Hex), and
decamethonium (Dec) were from Sigma.
Membrane.
Binding to membrane homogenate obtained from BOSC
23 cells transfected with the
4
4 and
6
4 subunits were
performed overnight by incubating aliquots of the membrane with
[3H]Epi concentrations ranging from 0.005 to 5 nM at 4°C. Nonspecific binding (averaging 5 to 10% of total binding)
was determined in parallel by means of incubation in the presence of
100 to 250 nM unlabeled Epi. A final concentration of 10 µg/ml of the
protease inhibitors leupeptin, bestatin, pepstatin A, aprotinin, and 2 mM PMSF was added to the incubation mixture to block possible proteolysis during the long incubation time of the assays. At the end
of the incubation, the samples were centrifuged and washed once with 10 sodium phosphate, pH 7.4, plus 50 mM NaCl, the pellet was dissolved
with 2N NaOH, and the filters counted in a
-counter.
[3H]Epibatidine Binding to Solubilized
Receptor.
Tissue extract binding was performed using DE52
ion-exchange resin (Whatman, Maidstone, UK) as previously described
(Vailati et al., 1999
). The binding techniques for immunoimobilized
subtype as well as the data analysis were the same as those described previously (Vailati et al., 1999
).
cDNA and Expression Vectors
The cDNAs encoding chick neuronal nAChR
4,
6, and
4
subunits cloned in the SV40-based expression vector Flip (Couturier et
al., 1990
; Nef et al., 1998
) were kindly provided by Dr. Marc Ballivet
(University of Geneva, Switzerland).
Expression of nACHR Subunits in BOSC23 Cells
Transient transfections of the nAChR subunits were carried out
in the retroviral packaging cell line BOSC 23, as described previously
(Ragozzino et al., 1997
). The cells were grown in Dulbecco's modified
Eagle's medium (Life Technologies, Gaithersburg, MD) supplemented with
10% fetal calf serum (Hyclone, Logan, UT). The subunit cDNAs were
added in equivalent amounts (8 µg each per 100-mm dish). Between 8 and 12 h after transfection, the cells were washed twice and fed
again with DME- containing 10% fetal calf serum. The cells were
collected in ice-cold phosphate-buffered saline (Life Technologies) 36 to 48 h after transfection, and stored at
70°C.
Materials
The protease inhibitors, cholinergic ligands, Triton X-100, and anti-rabbit and anti-rat antisera were purchased from Sigma, the nonradioactive Epi from RBI/Sigma, CnBr-activated Sepharose 4BCL and 125I-Protein A from Amersham Pharmacia Biotech, (±)[3H]Epi from PerkinElmer Life Sciences, and the reagents for gel electrophoresis from Bio-Rad Laboratories (Hercules, CA).
| |
Results |
|---|
|
|
|---|
Epibatidine Binding Receptors in the Retina during
Development.
We have reported previously (Vailati et al., 1999
)
that there is a high level of expression of
[3H]Epi-labeled receptors in 1-day-old chick
retina. To investigate the developmental expression of these receptors,
we performed binding studies using 2 nM [3H]Epi
and 2% retina extracts obtained from chicks on E7, E11, E14, E18, and
P1, and detected 50.3 ± 2, 162 ± 9, 220.7 ± 39, 264 ± 14, and 278 ± 21 fmol/mg of protein (mean ± S.E.M. of three experiments), respectively. If the binding to the same
extracts was performed in the presence of 1 µM cold
Bgtx, it
decreased to 41.4 ± 2.9, 105.7 ± 7, 155 ± 19, 199.9 ± 21, and 204.3 ± 16 fmol/mg of protein, respectively
(Fig. 1).
|
Bgtx-sensitive receptors make a
contribution at all developmental stages. This was also proved by
immunoprecipitation studies performed on E18 and P1 extracts not
incubated with
Bgtx, from which all of the additional
[3H]Epi binding was immunoprecipitated by
anti-
7 and/or -
8 Abs. The anti-
2 and -
4 Abs
immunoprecipitated the same amounts of 3H-labeled
receptors regardless of the presence of
Bgtx. These results are
consistent with the data previously reported by Gerzanich et al.
(1995)
8 and
7
Bgtx receptors.
[3H]Epi-labeled receptors are present as early
as E7; because their number increases by approximately 5- to 5.5-fold
from E7 to P1, we performed the following experiments using P1 retina.
4
4 Subtype Identification.
We have shown previously that
the [3H]Epi binding receptors present in P1
chick retina are a heterogeneous population: the majority contain the
4 subunit, but there is a subpopulation that also contains the
2
subunit with or without the
4 subunit. Furthermore, they are also
very heterogeneous in terms of their
subunit content (Vailati et
al., 1999
). Using anti-
6 subunit-specific Abs, we immunodepleted the
large majority of
6-containing receptors. The flow-through of the
6 affinity column still had receptors containing the
3,
2, and
4 subunits, and so we used anti-
3 and anti-
2 Abs in sequence,
to immunodeplete the retina extract of the residual
3 (Vailati et
al. 2000
) and
2-containing receptors. Further immunoprecipitation of
the flow-through obtained from the sequential columns confirmed the
almost total depletion of receptors containing the
6,
3, and
2
subunits (see Table 1), and indicated the
presence of 25% of 3H-labeled receptors that
were immunoreactive to the
4 and
4 subunits.
|
Subunit Composition of the
4
4 Subtype.
The retina
extract obtained after immunodepletion with the anti-
6, -
3, and
-
2 Abs was incubated with anti-
4 Abs bound to Sepharose, and the
bound receptors were eluted by competition with the
4 peptide or
glycine pH 2.2.
4 subtype, we
used immunoprecipitation to analyze the receptor eluted from the
affinity column by the corresponding
4 peptide. The
4 and
4
Abs immunoprecipitated the vast majority of
[3H]Epi-labeled receptors, with 79 ± 6, 63 ± 2, and 66 ± 4% of the receptors being
immunoprecipitated by the anti-
4-COOH, anti-
4-CYT, and monoclonal
Ab 299, respectively. The anti-
4-COOH and anti-
4-CYT immunoprecipitated 85 ± 3% and 77 ± 1% of the labeled
receptors. These results indicate that almost all of the purified
receptors contain both the
4 and
4 subunits. Because the
anti-
2, -
3, -
5, -
6, -
7, -
8, -
2 and -
3 Abs
immunoprecipitated these receptors to only a very limited extent, we do
not think that these subunits are coassembled with the
4 and
4
subunits in the immunopurified receptor (Fig.
2, top).
|
4
4 subtype with those performed on BOSC23 cells
transfected with the chick
4 and
4 subunits. The 2% Triton extract obtained from the transfected cells was labeled by
[3H]Epi and
immunoprecipitated using the same Abs as those used to characterize the
native subtype. Apart from a higher recovery with the
4 (98 ± 3 and 84 ± 7% with the anti-
4 COOH and CYT) and
4 Abs
(96 ± 3 and 89 ± 9% with the anti-
4 COOH and CYT), the
results were qualitatively very similar (Fig. 2, lower part).
The subunit composition of the purified native
4
4 receptors was
also analyzed on Western blots using the same Abs as those used for the
immunoprecipitation experiments (see Fig.
3). The anti-
4 Abs recognized a
peptide of 68 ± 0.9 kDa (anti-
4, lane 3) and the anti-
4 Abs
recognized a single band of 53 ± 0.5 kDa (anti-
4 CYT, lane 8;
anti-
4 COOH, lane 9) We also tested the purified
4
4 receptors
for the possible presence of
2 (lane 1),
3 (lane 2),
5 (lane
4),
6 (lane 5),
2 (lane 6), and
3 subunits (lane 7) but could
not detect any labeling using subunit-specific Abs. This was due to a
lack of proteins because the same Abs were able to recognize the
subunits in the purified
6
3
3
4 and
2
5
2 subtypes
(Gotti et al., 1994a
|
Pharmacological Profile of the Native
4
4 Subtype and
Comparison with the Transfected Subtype.
The pharmacological
experiments were all carried out on receptors immobilized by the
corresponding anti-
4-CYT specific Abs as described under
Experimental Procedures. The
4
4 receptors bind
[3H]Epi with high affinity; the
Kd value calculated from 10 separate experiments was 11 pM (CV, 17%).
4
4 receptors was
consistent with the presence of a single class of high-affinity binding
sites; it is also indicated by the Scatchard plot of the saturation
curve.
|
|
|
Cyt > Nic > DMPP > ACh > Carb: all
but Carb had relatively low Ki values (in
the low nanomolar range). The rank order of antagonist potencies was
DH
E > F3 > MII > MLA > MG624 > Dec > d-TC > Hex. DH
E was the most potent
antagonist, followed by F3, a compound that has nanomolar affinity for
the chick
7 subtype and has recently been found to block the native nAChRs expressed on the surface of rat chromaffin cells competitively and reversibly (Di Angelantonio et al., 2000
4 receptors, we also tested the binding of
[3H]Epi and ACh in receptors immunoimmobilized
on the anti-
4 COOH Abs, and found that the results were
qualitatively and quantitatively the same.
We also compared the pharmacological profiles of the native subtype
with that of the corresponding transfected
4
4 subtype. The BOSC
23
4
4 transfected cell line expresses a single class of
high-affinity [3H]Epi binding sites, with a
Kd of 18.3 pM (CV, 15%) and a
Bmax (mean ± S.E.M.) of 691 ± 204 fmol/mg of protein. Pharmacological experiments performed on cell
membranes obtained from transfected cells incubated for the same time
and with the same ligand concentrations as those used for the native
immunoimmobilized receptors gave an almost identical profile in terms
of the rank order and absolute values of the agonists (Epi
Cyt > Nic > Ach > DMPP > Carb); the pharmacological
profile of the antagonists was also very similar, with a rank order of
DH
E > F3 > MII > MG624 > MLA > d-TC > Dec > Hex. We found a maximum 3-fold
difference in the Ki values of d-TC, Dec, and Hex in the native and transfected cells.
These experiments performed on receptors with a known subunit
composition taken from transfected cells corroborated the results with
native receptors (Table 2).
Pharmacology of the Transfected
6
4 Chick Subtype.
To
study the role of the
4 and
4 subunits in the definition of the
pharmacological profile of the subtype, we characterized the profile of
the transfected chick
6
4 subtype (which has the same
4 subunit
but a different
subunit) and compared it with that of the
tranfected
4
4 subype.
6
4
cells also determined a single class of [3H]Epi
high-affinity sites, with a Kd value of 30 pM (CV, 18%) and a Bmax value of 74 ± 34 fmol/mg of protein. The order of agonist potency was Epi
Cyt > DMPP > ACh > Nic> Carb and that of the antagonists was MII
MLA > F3 > MG624 > Dh
E > d-TC > Dec > Hex (Table 2).
The
6
4 receptors had high nanomolar affinity for all of the
nicotinic agonists (except Carb) and the antagonists MII, MLA, F3 and
MG624 and micromolar affinity for the antagonists Dh
E, d-TC, Dec, and Hex. We have previously characterized the
pharmacology of the native
6
4-containing receptors expressed in
chick retina (see Table 2), which is very similar to that of the
transfected subtype. The only major difference was that MII, MLA,
MG624, and F3 had 15.3, 5.4, 10.2, and 6-fold higher affinity,
respectively, for the transfected than for the native subtype.
Comparison of the pharmacological profile of the transfected
6
4
and
4
4 subtypes shows that the major difference in
Ki values is for the agonist DMPP and the
antagonists MII, MLA, and d-TC, all of which had a higher
affinity for the
6
4 subtype. The main pharmacological difference
between the native and transfected
6
4 and
4
4 subtypes is
the much higher affinity of the
6
4 subtype for the MII toxin.
Figure 6 shows the inhibition curves of
MII on the membranes of the transfected
6
4 and
4
4 cells,
and on the immunonimmobilized native
6
4-containing and
4
4
retina subtypes. In agreement with our previously reported results for
the native
6-containing subtype (Ki = 66 nM), we found that MII had a high affinity for the
6
4
(Ki = 4.3 nM). Parallel pharmacological
experiments performed on the transfected
4
4 subtype
(Ki = 1750 nM) suggest that the high
affinity for the
6
4 subtype is attributable mainly to the
6
subunit.
|
| |
Discussion |
|---|
|
|
|---|
The pharmacological characteristics of chick, rat, and human
4
4 subtypes have been studied previously by electrophysiological and binding studies on receptors expressed in heterologous systems (Luetje and Patrick, 1991
; Chavez-Noriega et al., 1997
; Ragozzino et
al., 1997
; Stauderman et al., 1998
), but this is the first biochemical
and immunological demonstration of its presence in vertebrate CNS.
The results described here, together with those of our previous
studies, indicate that 70 to 75% of the
Bgtx-insensitive [3H]Epi-labeled receptors in chick retina
contain the
4 subunit, which is the predominant retina subunit at
P1. This subunit it is coassembled with the
6 subunit in 30 to 35%
of the receptors (Vailati et al., 1999
), with
3 in 5 to 10% of the
receptors (Vailati, 2000
), with
2 in 10 to 15%, and with
4 in 20 to 25%.
No direct evidence exists for the physiological role of these subtypes,
but they might be involved in fine tuning the spontaneous activity
required for the development of circuits in the retina and/or the
formation of the appropriate retina-tectum connections. This role of
nAChRs in the retina circuits is also suggested by the recent findings
of altered spontaneous activity patterns in the retina of mice lacking
the
2 and/or
4 nicotinic subunits (Bansal et al., 2000
).
We have shown that both the
Bgtx-sensitive and -insensitive
receptors in the retinas of 1-day-old chicks contribute to the high
affinity of [3H]Epi binding. The
Bgtx-sensitive receptors are those that contain the
7 and/or
8
subunits, whereas the
Bgtx-insensitive receptors include multiple
subtypes, 25% of which contain the
4 and
4 subunits. These
[3H]Epi-labeled receptors increase by 5- to
6-fold during retina development. At E7, most of the
Bgtx-insensitive [3H]Epi binding is caused
by receptors containing the
4,
3, and
2 subunits (S.V., M.M.,
and C.G., unpublished observations) whereas a large number of
receptors also contain the
3,
4, and
6 subunits at P1. We
(Gotti et al., 1994b
) and others (Keyser et al., 1993
) have previously
shown that there is also a developmental increase in chick retina
Bgtx binding receptors, which correlates with an increase in the
number of receptors containing the
8 subunit.
Having established that P1 was the developmental time with the largest
increase in [3H]Epi-labeled receptors
insensitive to
Bgtx, we used a series of immunodepletetion
procedures to purify the native
4
4 subtype from the retina of
1-day-old chicks.
We analyzed the subunit composition of the purified
4
4 subtype by
means of Western blot and immunoprecipitation experiments using Abs
directed against all of the known chick nicotinic subunits. The blots
of the purified subtypes were recognized only by the Abs directed
against the
4 and
4 subunits. These results were confirmed in the
immunoprecipitation studies in which only the anti-
4 and
4 Abs
immunoprecipitated more than 63% of the immunopurified [3H]Epi labeled receptors. To control the
specificity of our immunoprecipitation studies, we performed the same
immunoprecipitation experiment on 2% Triton extracts obtained from
4
4 transfected BOSC 23 cells. We obtained the same qualitative
results with a higher recovery (more than 83% of the
[3H]Epi-labeled receptors
were immunoprecipitated), which suggests that the lower recovery of the
purified receptors is probably caused by partial proteolysis during the
long purification processes. The absence of immunoprecipitation with
the other Abs in the native receptors is caused by the lack of
subunits, because the same Abs were able to immunoprecipitate the
receptors containing the corresponding subunits in control experiments.
Binding studies of the
4
4 subtype showed no difference in the
affinity of the native and transfected subtypes for a number of
nicotinic ligands: both had nanomolar affinity for the agonists and the
DH
E antagonist, and micromolar affinity for the toxins MII and MLA.
The highest agonist affinity was for Epi followed by Cyt, and the
Ki values of ACh, Epi, and Cyt were very
similar to those reported in the oocyte-transfected rat
4
4
subtype (Parker et al., 1998
). The chick
4
4 subtype has a higher
affinity for Dh
E than the native
4
2 subtype (Balestra et al.,
2000
), which is in agreement with the results obtained in
electrophysiological experiments using oocyte-expressed rat (Harvey et
al., 1996
) and human subtypes (Chavez-Noriega et al., 1997
).
Comparison of the pharmacological profile of the native
4
4
subtype with that of the
6
4 subtype also present in chick retina shows that the two subtypes have different
Ki values for the toxin MII, DH
E,
d-TC, and F3. Because our purified
6
4-containing receptors make up a heterogeneous population in which 40 to 50% also
have an additional
3 and/or
3 subunit, we investigated the
affinity of these and other nicotinic ligands in the transfected
6
4 chick subtype. The pharmacological profile of the
6
4
subtype was similar but not identical to that reported previously for the native subtype: it has a high affinity for agonists, micromolar affinity for DH
E, and an even higher affinity for the toxins MII
(Ki = 4.5 nM) and MLA
(Ki = 247 nM) and for the oxystilbene derivatives F3 (Ki = 264 nM) and MG624
(Ki = 440 nM). The high affinity for the
MLA toxin is in agreement with the electrophysiological results
obtained by Fucile et al. (1998)
, who found that 10 µM MLA is able to
block the ACh-induced current in the same transfected subtype.
The pharmacological properties of the transfected
4
4 subtype
reflect those of the native receptors, but the transfected and native
6
4 subtypes differ in terms of the absolute
Ki values of some antagonists, thus
suggesting that the presence of the
3 and/or
3 subunit may play a
role in the definition of antagonist affinity in the native
6
4
subtype. The binding affinity of agonists and antagonists depends on
both the
and
subunits (Parker et al., 1998
). The greatest
difference occurs as a consequence of changing the
subunit, but
differences are also seen when the
subunit is changed. In the
present study, we found that the Ki values
of the MII toxin for the transfected
6
4 and
4
4 subtypes (which differ only in terms of the
subunit), are more than 400 times different. This result allows us to conclude that the MII toxin
has a high affinity for the chick
6
4 subtype
(Ki = 4.5 nM), and that this high affinity
is mainly caused by the
6 subunit because both the native and
transfected
4
4 subtypes have only micromolar affinity for MII.
The results obtained in binding studies are in agreement with the very
recent finding by Kuryatov et al. (2000)
that MII toxin not only
inhibits the ACh-induced currents in the
3
2 oocyte-expressed subtype (as also reported previously by Cartier et al., 1996
) but also
potently inhibits both the chimeric
6/
3 and
6/
4 receptors containing either
2 or
4 subunits.
The high affinity of MII toxin on
6-containing receptors could be
very important for dissecting the role of this subtype in brain
function and, in particular, for improving our understanding of the
addictive properties of nicotine. It has been suggested that the
behavioral effects of nicotine depend on dopamine (Di Chiara, 2000
),
and mRNA for the
6 subunit is in dopaminergic nuclei projecting to
the striatum (Le Novère et al., 1996
) and MII toxin partially
blocks the dopamine release from striatal synaptosomes (Kulak et al.,
1997
).
It is difficult to attribute specific functional roles to the
4
4
subtype in the CNS because its presence has only been demonstrated in
chick retina and could be species-specific. Furthermore, studies performed in KO mice suggest that, if present, it is only a minor subtype: ligand binding and electrophysiological studies in
2 KO animals (Zoli et al., 1998
)
have suggested that
4
4 receptors could be present in the
interpeduncular nucleus and medial habenula, but the results of later
binding studies of
4 KO animals (Marubio et al., 1999
) make this
possibility very unlikely.
It has recently been found that cocaine, a drug of abuse that primarily
blocks the dopamine and serotonin transporters, also affects the
heterologously expressed
4
4 rat subtype at concentrations compatible with those present in the serum of cocaine users (Francis et
al., 2000
). If this is proven true for the native subtype, a new
pharmacological tool will be available for the study of this subtype in vivo.
| |
Acknowledgments |
|---|
We would like to thank Prof. Fabrizio Eusebi for critically reading the manuscript and Mr. Kevin Smart and Ms. Ida Ruffoni for their aid with the manuscript.
| |
Footnotes |
|---|
Received December 4, 2000; Accepted February 14, 2000
This work was supported in part by grants to F.C. from the Italian Ministry of University and Scientific and Technological Research (MM05152538) and from the European "Training and Mobility of Researchers" Program (contract ERB4061PL97-0790).
B.B. and S.V. contributed equally to this work.
Send reprint requests to: Dr. Cecilia Gotti, CNR Cellular and Molecular Pharmacology Center, Via Vanvitelli 32, 20129 Milano, Italy. E-mail: c.gotti{at}csfic.mi.cnr.it
| |
Abbreviations |
|---|
ACh, acetylcholine;
CNS, central nervous
system;
nAChR, neuronal nicotinic acetylcholine receptor;
COOH, subunit
COOH peptide;
CYT, subunit cytoplasmic peptide;
Ab, polyclonal
antibody;
PMSF, phenylmethylsulfonyl fluoride;
Epi, epibatidine;
MII,
-conotoxin MII;
Bgtx,
-bungarotoxin;
Carb, carbamylcholine;
Cyt, cytisine;
DMPP, 1,1-dimethyl-4-phenylpiperazinium;
Nic, nicotine;
MLA, methyllycaconitine;
DH
E, dihydro-
-erythroidine;
d-TC, d-tubocurarine;
Hex, hexamethonium;
Dec, decamethonium;
CV, coefficient of variation.
| |
References |
|---|
|
|
|---|
2
5
2 nicotinic receptor subtype.
Mol Pharmacol
58:
300-311
-conotoxin which targets
3
2 nicotinic acetylcholine receptors.
J Biol Chem
271:
7522-7528
2
2, h
2
4, h
3
2, h
3
4, h
4
4, and h
7 expressed in Xenopus oocytes.
J Pharmacol Exp Ther
280:
346-356
7) is developmentally regulated and forms a homooligomeric channel blocked by
-Bungarotoxin.
Neuron
5:
847-856[Medline].
3 and
4 subunits of the rat nicotinic receptor.
J Neurosci
17:
1531-1538
4 and
4 subunits.
Mol Pharmacol
58:
109-119
6 subunit forms functional heteromeric acetylcholine receptors in human transfected cells.
Eur J Neurosci
10:
172-178[Medline].
-bungarotoxin receptors.
Br J Pharmacol
124:
1197-1206[Medline].
7 and
7-
8
-Bungarotoxin receptor subtypes immunopurified from the chick optic lobe.
Eur J Neurosci
6:
1281-1291[Medline].
-bungarotoxin receptor subtypes in chick central nervous system during development.
J Rec Res
14:
335-346.
-erythroidine sensitivity on rat neuronal nicotinic receptor
subunits.
J Neurochem
67:
1953-1959[Medline].
Bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina.
J. Neurosci
13:
442-454[Abstract].
-Conotoxin MII blocks nicotine stimulated dopamine release in rat striatal synaptosomes.
J Neurosci
17:
5263-5270
6 AChR subtypes: subunit composition, assembly and pharmacological responses.
Neuropharmacol
39:
2570-2590[Medline].
6 subunit mRNA is selectively concentrated in catecholami